Comparison of height and weight after 12 vs. 18 Gy cranial radiation therapy in pediatric acute lymphoblastic leukemia (ALL) patients

scientific article published on February 2017

Comparison of height and weight after 12 vs. 18 Gy cranial radiation therapy in pediatric acute lymphoblastic leukemia (ALL) patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.ADRO.2017.01.010
P932PMC publication ID5514256
P698PubMed publication ID28740936

P2093author name stringKala Y Kamdar
M Fatih Okcu
Arnold C Paulino
Eunji Jo
ZoAnn E Dreyer
Albert C Chen
Rona Y Sonabend
Hilary S Suzawa
P2860cites workTreating childhood acute lymphoblastic leukemia without cranial irradiationQ24644599
Disproportionate short stature after cranial irradiation and combination chemotherapy for leukaemiaQ33624689
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study GroupQ33903257
Excellent therapeutic efficacy and minimal late neurotoxicity in children treated with 18 grays of cranial radiation therapy for high-risk acute lymphoblastic leukemia: a 7-year follow-up study of the Dana-Farber Cancer Institute Consortium ProtocolQ34083342
Final height and body mass index in adult survivors of childhood acute lymphoblastic leukemia treated without cranial radiotherapy: a retrospective longitudinal multicenter Italian studyQ34325688
Height and weight pattern up to 20 years after treatment for acute lymphoblastic leukaemiaQ35260453
Normal tissue development, homeostasis, senescence, and the sensitivity to radiation injury across the age spectrumQ37643965
Results and significance of six randomized trials in four consecutive ALL-BFM studiesQ37913555
Prophylaxis and treatment of leukemia in the central nervous system and other sanctuariesQ39823448
A comparative study of central nervous system irradiation and intensive chemotherapy early in remission of childhood acute lymphocytic leukemiaQ44738780
Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment.Q44895056
The increasing incidence of central nervous system leukemia in children. (Children's Cancer Study Group A).Q44975497
Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.Q46923027
Growth hormone secretion, puberty and adult height after cranial irradiation with 18 Gy for leukaemiaQ47279739
Normal final height after treatment for acute lymphoblastic leukemia without irradiationQ47365992
Final height after treatment for childhood acute lymphoblastic leukemia: comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiationQ47391535
Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: a report from the childhood cancer survivor studyQ47407745
Height impairment after lower dose cranial irradiation in children with acute lymphoblastic leukemiaQ47415320
A longitudinal study on growth and spontaneous growth hormone (GH) secretion in children with irradiated brain tumorsQ48188785
Growth failure after treatment of pediatric brain tumorsQ48274320
Prophylactic cranial irradiation of acute lymphoblastic leukemia in childhood: outcomes of late effects on pituitary function and growth in long-term survivors.Q48614820
Radiation dose-volume effects on growth hormone secretion.Q48630363
Effects of low-dose cranial radiation on growth hormone secretory dynamics and hypothalamic-pituitary functionQ48955141
Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report.Q53023089
Growth response to growth hormone therapy following cranial irradiationQ62750467
Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimenQ64225688
Pubertal growth in young adult survivors of childhood leukemiaQ71832932
Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukaemia: comparison of 1800 rad and 2400 rad. A report for Children's Cancer Study GroupQ72452783
Longitudinal growth and risk factors for growth deficiency in children treated for acute lymphoblastic leukemiaQ83340964
P433issue2
P921main subjectlymphoblastic leukemiaQ18553852
P304page(s)228-234
P577publication date2017-02-01
P1433published inAdvances in radiation oncologyQ27727236
P1476titleComparison of height and weight after 12 vs. 18 Gy cranial radiation therapy in pediatric acute lymphoblastic leukemia (ALL) patients
P478volume2